Biodexa Pharmaceuticals Plc Share Price (NASDAQ: BDRX)

Biodexa Pharmaceuticals Plc Stock Performance

as on October 16, 2025 at 1:29 am IST

Day's Low
Day's High
$7.84
Day's Price Range
$8.4
$8.13
3.57%
Downside
3.32%
Upside
52 Week's Low
52 Week's High
$5
52-Week Price Range
$108.9
$8.13
38.50%
Downside
1239.48%
Upside

Biodexa Pharmaceuticals Plc share price movements today

Previous Close: $8.40
Open: $7.84
Volume: 160.7K
Day's Low - High: $7.84 - $8.4
52 Week Low - High: $5 - $108.9

Biodexa Pharmaceuticals Plc Historical Returns

1 Month Return: + 29.55 %
3 Month Return: -3.22 %
1 Year Return: -90.35 %
3 Year Return: 0 %
5 Year Return: 0 %

Biodexa Pharmaceuticals Plc Stock Fundamentals & Key Indicators

Check Biodexa Pharmaceuticals Plc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$5.2M

EPS (TTM)

-0.4

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-8.9M

Revenue (TTM)

83.0K

Profit Margin

0.00%

Return On Equity TTM

55446800.00%

Biodexa Pharmaceuticals Plc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Biodexa Pharmaceuticals Plc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Biodexa Pharmaceuticals Plc	BUY	$5.2M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$61.5B	223.43%	-505.15	-12.96%
Beone Medicines Ltd	NA	$37.1B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$105.7B	87.04%	28.99	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.6B	-3.89%	14.07	31.37%

Stock Returns calculator for Biodexa Pharmaceuticals Plc Stock including INR - Dollar returns

The Biodexa Pharmaceuticals Plc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Biodexa Pharmaceuticals Plc investment value today

Current value as on today

₹14,510

Returns

₹85,490

(-85.49%)

Returns from Biodexa Pharmaceuticals Plc Stock

₹90,321 (-90.32%)

Dollar Returns*

₹4,831 (+4.83%)

Analyst Recommendation on Biodexa Pharmaceuticals Plc Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Biodexa Pharmaceuticals Plc. Average target price of $180.99

Biodexa Pharmaceuticals Plc Share Price Target

Get share price movements and forecasts by analysts on Biodexa Pharmaceuticals Plc.

What analysts predicted

95.51%UPSIDE

Target Price

$180.99

Current Price

$8.13

Analyzed by

7 Analysts

Target

$180.99

Biodexa Pharmaceuticals Plc target price $180.99, a slight upside of 95.51% compared to current price of $8.13. According to 7 analysts rating.

Biodexa Pharmaceuticals Plc Stock’s Investor Sentiment and Interest

Search interest for Biodexa Pharmaceuticals Plc Stock has increased by 115% in the last 30 days, reflecting an upward trend in search activity.

Time period: September 16, 2025 to October 16, 2025

Change:115% versus previous 30 day period

Biodexa Pharmaceuticals Plc Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023
Total Revenue	0	0	0	0	0	0
Gross Profit	-1	-3	-1	-2	-1	-2
Operating Income	-1	-3	-2	-4	-1	-3
EBITDA	-1	-3	-2	-4	-1	-2
Interest Expense	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-
Income Before Tax	-2	-5	-1	-3	-1	-3
Income Tax Expense	0	0	0	0	0	0
Net Income	-2	-5	-2	-4	-1	-3
Net Profit Margin	-1989.18%	-1989.18%	-1197.32%	-1197.32%	-4230.12%	-4230.12%

Biodexa Pharmaceuticals Plc Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	1	1	0	1	0	0	0	0	0	-
Gross Profit	1	-6	-7	-7	-9	-7	-5	-5	-4	-6
Operating Income	-10	-9	-11	-11	-11	-23	-6	-8	-8	-9
EBITDA	-10	-5	-10	-10	-9	-22	-5	-8	-7	-9
Interest Expense	-	-	0	0	0	0	0	0	0	0
Depreciation	-	-	-	-	1	1	0	0	0	0
Income Before Tax	-11	-8	-12	-12	-10	-23	-6	-8	-7	-5
Income Tax Expense	1	2	1	2	1	1	0	0	0	0
Net Income	-10	-6	-11	-10	-13	-29	-7	-9	-8	-7
Net Profit Margin	-734.47%	-465.68%	-1183.52%	-534.98%	-1496.29%	-6469.10%	-944.64%	-1095.28%	-1858.01%	0.00%

Biodexa Pharmaceuticals Plc Quarterly Cash Flow

All numbers in Millions USD

	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Dec 2024	Jun 2025
Net Income	-4	-1	-3	-1	-3	-1	-3	-2	-3
Operating Cash Flow	-3	-1	-3	-1	-2	-2	-4	-7	-3
Investing Cash Flow	0	0	0	-	0	-	0	0	0
Financing Cash Flow	0	3	6	1	3	2	4	3	6
Change in Cash	-1	1	1	0	0	0	5	-5	4

Biodexa Pharmaceuticals Plc Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-20	-16	-15	-10	-22	-5	-7	-7	-5
Operating Cash Flow	-13	-12	-13	-6	-9	-6	-7	-6	-12
Investing Cash Flow	-1	-1	9	-3	2	0	0	0	0
Financing Cash Flow	15	10	-6	18	3	8	0	10	8
Change in Cash	1	-4	-10	8	-3	2	-7	3	-4

Insights on Biodexa Pharmaceuticals Plc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 41.5K → 83.0K (in $), with an average increase of 50.0% per quarter
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 56.5% return, outperforming this stock by 146.8%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, -2.42M → -3.80M (in $), with an average decrease of 57.2% per quarter
NEGATIVE IMPACT
Price Dip
In the last 7 days, BDRX stock has moved down by -25.6%

About Biodexa Pharmaceuticals Plc

midatech is a world leader in the design, synthesis and manufacture of biocompatible gold nanoparticles (gnps) with a core focus on therapeutics for diabetes and cancer. midatech has a strong pipeline of product candidates in clinical and pre-clinical development for the treatment of diabetes and various cancers. in 2012, midatech established midasol therapeutics lp, a strategic joint venture with monosol rx llc to focus on the development and commercialization, via partnering or licensing, of products primarily for the treatment of diabetes. midasol’s lead product, midaform™ insulin pharmfilm, is a unique product for the oral delivery of insulin in diabetic patients and will enter phase ii clinical studies in 2014. these technologies are also being evaluated in the diabetes area by a major us pharmaceutical company. midatech’s unique gnp technology enables the administration and targeted delivery of therapeutic compounds to specific cells and tissues. multiple drug molecules can b

Organisation	Biodexa Pharmaceuticals Plc
Headquarters	1 Caspian Point, Cardiff, United Kingdom, CF10 4DQ
CEO	Mr. Stephen Anthony Stamp
E-voting on shares	Click here to vote

Key Management of Biodexa Pharmaceuticals Plc

Name	Title
Mr. Stephen Anthony Stamp	CEO, CFO, Company Secretary & Director
Dr. Daniel Palmer MBA, Ph.D.	Vice President of Technology
Mr. Steve Ellul	Chief Business Officer
Dr. Gary A. Shangold CPI, FACOG, M.D.	Chief Medical Officer
Noreen Bhatti	Vice President of Clinical Operations
Ms. Fiona Sharp	Group Financial Controller

FAQs

What is Biodexa Pharmaceuticals Plc share price today?

Biodexa Pharmaceuticals Plc share price today is $8.13 as on October 16, 2025 at 1:29 am IST at the close of the market. Biodexa Pharmaceuticals Plc share today touched a day high of $8.4 and a low of $7.84.

What is the 52 week high and 52 week low for Biodexa Pharmaceuticals Plc share?

Biodexa Pharmaceuticals Plc share touched a 52 week high of $108.9 on October 16, 2024 and a 52 week low of $5 on September 8, 2025. Biodexa Pharmaceuticals Plc stock price today i.e. October 16, 2025 at 1:29 am IST is closed at $8.13,which is 92.53% down from its 52 week high and 62.60% up from its 52 week low.

What is Biodexa Pharmaceuticals Plc's market capitalisation today?

Biodexa Pharmaceuticals Plc market capitalisation is $0.00T as on October 16, 2025 at 1:29 am IST.

How to invest in Biodexa Pharmaceuticals Plc Stock (BDRX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Biodexa Pharmaceuticals Plc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Biodexa Pharmaceuticals Plc Shares that will get you 0.1845 shares as per Biodexa Pharmaceuticals Plc share price of $8.13 per share as on October 16, 2025 at 1:29 am IST.

What is the minimum amount required to buy Biodexa Pharmaceuticals Plc Stock (BDRX) from India?

Indian investors can start investing in Biodexa Pharmaceuticals Plc (BDRX) shares with as little as ₹87.985 or $1 (as of October 16, 2025 at 2:41 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹879.85 in Biodexa Pharmaceuticals Plc stock (as per the Rupee-Dollar exchange rate as on October 16, 2025 at 2:41 pm IST). Based on Biodexa Pharmaceuticals Plc share’s latest price of $8.13 as on October 16, 2025 at 1:29 am IST, you will get 1.2300 shares of Biodexa Pharmaceuticals Plc. Learn more about fractional shares .